MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,125 | -99.9% | 1,500,000 | 0.0% | 0.06% | +14.5% |
| Q3 2022 | $1,292,000 | -23.1% | 1,500,000 | 0.0% | 0.06% | -38.9% |
| Q2 2022 | $1,680,000 | 0.0% | 1,500,000 | 0.0% | 0.09% | +28.6% |
| Q1 2022 | $1,680,000 | -30.0% | 1,500,000 | 0.0% | 0.07% | +7.7% |
| Q4 2021 | $2,400,000 | -33.9% | 1,500,000 | 0.0% | 0.06% | -19.8% |
| Q3 2021 | $3,630,000 | -23.7% | 1,500,000 | 0.0% | 0.08% | -16.5% |
| Q2 2021 | $4,755,000 | -5.9% | 1,500,000 | 0.0% | 0.10% | +9.0% |
| Q1 2021 | $5,055,000 | – | 1,500,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |